• Mon, July 10, 2017
  • Tue, July 11, 2017
  • Wed, July 12, 2017

Matthew Harrison Maintained (BIIB) at Hold with Decreased Target to $301 on, Jul 10th, 2017

Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $307 to $301 on, Jul 10th, 2017.

Matthew has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "UBS" Upgraded from Strong Sell to Hold on, Monday, June 19th, 2017
  • Geoffrey Porges of "Leerink Swann" Downgraded from Buy to Hold on, Thursday, March 16th, 2017


This is the rating of the analyst that currently disagrees with Matthew


  • Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017